Immunohistochemical detection of NAD(P)H:Quinone oxidoreductase in human lung and lung tumors

Clinical Cancer Research

Volumn 4, Issue 9, 1998, Pages 2065-2070

  Siegel, David ^a   Franklin, Wilbur A ^a   Ross, David ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN C; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ARTICLE; BRONCHUS CARCINOID; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG TUMOR; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; LUNG NEOPLASMS; NAD(P)H DEHYDROGENASE (QUINONE); SENSITIVITY AND SPECIFICITY;

EID: 0031666337     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Thor, H., Smith, M. T., Hartzell, P., Bellomo, G., Jewell, S. A., and Orrenius, S. The metabolism of menadione (2-methyl-1,4-napthoquinone) by isolated hepatocytes. J. Biol. Chem., 257: 12419-12425, 1982.
2. Lind, C., Hochstein, P., and Ernster, L. DT-diaphorase as a quinone reductase. A cellular control device against semiquinone and superoxide radical formation. Arch. Biochem. Biophys., 216: 178-185, 1982.
3. Siegel, D., Gibson, N. W., Preusch, P. C., and Ross, D. Metabolism of mitomycin C by DT-diaphorase: role of mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells. Cancer Res., 50: 7483-7489, 1990.
4. Siegel, D., Hartman, C., Beall, H., Kasai, M., Arai, H., Gibson, N. W., and Ross, D. Bioreductive activation of mitomycin C by DT-diaphorase. Biochemistry, 31: 7879-7885, 1992.
5. Walton, M. I., Bibby, M. C., Double, J. A., Plumb, J. A., and Workman, P. DT-diaphorase activity correlates with sensitivity to the indoloquinone EO9 in mouse and human colon carcinomas. Eur. J. Cancer, 28A: 1597-1600, 1992.
6. Beall, H. D., Yafei, L., Siegel, D., Gibson, N. W., and Ross, D. Role of NAD(P)H:quinone oxidoreductase (DT-diaphorase) in cytotoxicity and induction of DNA damage by streptonigrin. Biochem. Pharmacol., 51: 645-652, 1996.
7. Gibson, N. W., Hartley, J. A., Butler, J., Siegel, D., and Ross, D. The relationship between DT-diaphorase mediated metabolism of a series of aziridinylbenzoquinones and DNA damage and cytotoxicity. Mol. Pharmacol., 42: 531-536, 1992.
8. Siegel, D., Gibson, N. W., Preusch, P. C., and Ross, D. Metabolism of diaziquone (AZQ) by NAD(P)H (quinone acceptor) oxidoreductase (DT-diaphorase). Role in AZQ-induced DNA damage and cytotoxicity in human colon carcinoma cells. Cancer Res., 50: 7293-7300, 1990.
9. Workman, P. Enzyme directed bioreductive drug development revisited: a commentary on recent progress and future prospects with emphasis on quinine anticancer agents and quinone metabolizing enzymes, particularly DT-diaphorase. Oncol. Res., 6: 461-475, 1994.
10. Winski, S. L., Hargreaves, R. H. J., Butler, J., and Ross, D. New aziridinylbenzoquinones as NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor agents. Proc. Am. Assoc. Cancer Res., 30: 2072, 1998.
11. Cresteil, T., and Jaiswal, A. K. High levels of expression of the NAD(P)H:quinone oxidoreductase (NQO1) gene in tumor cells compared to normal cells of the same origin. Biochem. Pharmacol., 42: 1021-1027, 1991.
12. Schlager, J. J., and Powis, G. Cytosolic NAD(P)H (quinone-acceptor) oxidoreductase in human normal and tumor tissue: effects of cigarette smoking and alcohol. Int. J. Cancer, 45: 403-409, 1990.
13. Smitskamp-Wilms, E., Giaccone, G., Pindo, H. M., van der Laan, B. F. A. M., and Peters, G. J. DT-diaphorase activity in normal and neoplastic human tissues; an indicator for sensitivity to bioreductive agents? Br. J. Cancer, 72: 917-921, 1995.
14. Marin, A., Lopez de Ceraain, A., Hamilton, E., Lewis, A. D., Martinez-Penuela, J. M., Idoate, M. A., and Bello, J. DT-diaphorase and cytochrome B5 reductase in human lung and breast tumours. Br. J. Cancer, 76: 923-929, 1997.
15. Sreerama, L., and Sladek, N. E. Cellular levels of class 1 and class 2 aldehyde dehydrogenases and certain other drug-metabolizing enzymes in human breast malignancies. Clin. Cancer. Res., 3: 1901-1914, 1997.
16. Berger, M. S., Talcott, R. E., Rosenblum, M. L., Silva, M., Aliosman, F., and Smith, M. T. The use of quinones in brain tumor chemotherapy. Preliminary results from preclinical investigations. J. Toxicol. Environ. Health, 16: 713-719, 1985.
17. Malkinson, A. M., Siegel, D., Forrest, G. L., Gazdar, A. F., Oie, H. K., Chan, D. C., Bunn, P. A., Mabry, M., Dykes, D. J., Harridan, S. D., Jr., and Ross, D. Elevated DT-diaphorase activity and mRNA content in human non-small cell lung carcinoma. Relationship to the response of lung tumor xenographs to mitomycin C. Cancer Res., 52: 4752-4757, 1992.
18. Traver, R. D., Siegel, D., Beall, H. D., Phillips, R. M., Gibson, N. W., Franklin, W. A., and Ross, D. Characterization of a polymorphism in NAD(P)H:quinone oxidoreductase (DT-diaphorase). Br. J. Cancer, 75: 69-75, 1997.
19. Ross, D., Siegel, D., Beall, H., Mulcahy, R. T., Prakash, A. S., and Gibson, N. W. Activation and detoxification of quinones by DT-diaphorase. Bioreductive activation of mitomycin C. Cancer Metastasis Rev., 12: 83-101, 1993.
20. Knox, R. J., Boland, M. P., Friedlos, F., Coles, B., Southan, C., and Roberts, J. J. The nitroreductase enzyme in Walker cells that activates 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954) to 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamine is a form of NAD(P)H dehydrogenase (quinone) (EC1.6.99.2). Biochem. Pharmacol., 37: 4671-4677, 1988.
21. Schmeltz, I., Tosk, J., Jacobs, G., and Hoffman, D. Redox potential and quinone content of cigarette smoke. Anal. Chem., 49: 1924-1929, 1977.
22. Church, D. F., and Pryor, W. A. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ. Health Perspect., 64: 111-126, 1985.
23. Ross, D., Siegel, D., Schattenberg, D. G., Sun, X. M., and Moran, J. L. Cell-specific activation and detoxification of benzene metabolites in mouse and human and human bone marrow: identification of target cells and a potential role for modulation of apoptosis in benzene toxicity. Environ. Health Perspect., 104: 1177-1182, 1996.
24. Smart, R. C., and Zannoni, V. G. DT-diaphorase and peroxidase influence the covalent binding of the metabolites of phenol, the major metabolite of benzene. Mol. Pharmacol., 26: 105-111, 1984.
25. Siegel, D., Bolton, E. M., Burr, J. A., Liebler, D. C., and Ross, D. The reduction of α-tocopherolquinone by human NAD(P)H:quinone oxidoreductase: the role of α-tocopherolhydroquinone as a cellular antioxidant. Mol. Pharmacol., 52: 300-305, 1997.
26. Beyer, R. E., Segura-Aguilar, J., Di Bernardo, S., Cavazzoni, M., Fato, R., Fiorentini, D., Galli, M., Setti, M., Landi, L., and Lenaz, G. The role of DT-diaphorase in the maintenance of the reduced antioxidant form of coenzyme Q in membrane systems. Proc. Natl. Acad. Sci. USA, 93: 2528-2532, 1996.
27. Sreerama, L., Hedge, M. W., and Sladek, N. E. Identification of a class 3 aldehyde dehydrogenase in human saliva and increased levels of this enzyme, glutathione S-transferases and DT-diaphorase in the saliva of subjects who continually ingest large quantities of coffee or broccoli. Clin. Cancer Res., 1: 1153-1163, 1995.
28. Ross, D., Kepa, J., McGuinness, S. M., and Siegel, D. Studies of a polymorphism in NAD(P)H:quinone oxidoreductase (NQO1). Proc. Am. Assoc. Cancer Res., 30: 2485, 1998.